Financing Overview - From January 19 to January 25, Shanghai enterprises reported 19 financing events, with 7 disclosing financing amounts, totaling 2.97 billion yuan. This week saw 5 fewer financing events compared to the previous week [2] - Among the districts in Shanghai, Pudong New District had the highest number of financing events at 12, while other districts had 1-2 events each. Jing'an District reported a significant D-round financing of 287 million USD, and Jinshan District had a B-round financing of approximately 100 million USD [2] Financing Events Artificial Intelligence - Deep Sky Core completed tens of millions in angel + round financing on January 23, led by Friendship Time and Yuanhe Origin, with funds aimed at advancing the development of "intention understanding" embodied intelligent brains and ultra-realistic human face iterations [4] - Left Eye Entertainment secured 1 million yuan in seed round financing on January 17, exclusively invested by Jiangxia Ke Investment Group [5] - Dream Technology completed B-round financing on January 19, exclusively funded by Bofut Fund [6] - Aike Easy Intelligent finished seed round financing on January 21, with investment from Pudong Venture Capital Group, to accelerate the development of the next-generation AiOFFICE collaboration platform [7] Integrated Circuits - Taorun Semiconductor completed several hundred million yuan in D++ round financing on January 26, led by Xicheng Jinrui, with participation from multiple institutions, including existing shareholders who increased their investments. The funds will support the continuous iteration of high-end analog underlying technology and the development of next-generation optical communication DSP chips [8] - ThinkForce completed strategic financing on January 16, exclusively invested by Shanghai Science and Technology Innovation Group [9] - Langxi Technology secured Pre-A round financing on January 21, with investments from Shijue Investment, Xianfeng, Dongfang Fuhai, and Jinpu Investment [10] Biomedicine - CORXEL completed 287 million USD in D-round financing on January 23, with investments from multiple firms, aimed at supporting clinical trials for oral small molecule GLP-1 receptor agonist CX11 and advancing other cardiovascular metabolic projects [11] - Shengqida completed Pre-A round financing on January 19, led by Yida Capital, with participation from Nuoxin Fund [12] - Xinhenglv Medical secured angel round financing on January 20, exclusively invested by Xianfeng [13] Future Industries - Yipujiji completed approximately 100 million USD in B-round financing on January 23, led by Forebright and Silicon Peak, with additional investments from several venture capital firms. The funds will be used for capacity expansion, operational funding, and global market expansion, particularly for high-power density data centers driven by AI computing [14] - Yitan Shuke completed A+ round financing on January 20, with investments from Beichuang Investment and Beijing Guoneng Fund [15] - Feijiesike completed nearly 100 million yuan in Pre-A round financing on January 23, with investments from Chixing Venture Capital and others, aimed at accelerating the development of the physical AI sector [16] - Niuwashike completed A round financing on January 19, with investments from Xinhai Asset and Zhejiang Tongxing [17] - Wanhuyuan Bio completed several million yuan in A round financing on January 21, led by Jinsha River United Capital, aimed at advancing the application of its intelligent microphysiological organoid system in precision medicine and new drug development [18]

Core Insights - Shanghai Taorun Semiconductor Co., Ltd. has completed a new round of financing amounting to several hundred million yuan in D++ round, led by Xicheng Jinrui with participation from multiple institutions including Xinwei Capital, Galaxy Yuanhui, Zhongyuan Capital, and Jinma Investment, along with additional investments from existing shareholders [1] Group 1: Financing and Investment - The funds from this financing round will be used for the continuous iteration of high-end analog underlying technology and the subsequent research and development of next-generation optical communication DSP chips [1] - The company was established in 2015, with a registered capital of 20.83 million yuan, and is involved in technology development, transfer, consulting, and services in the semiconductor and computer technology fields [1] Group 2: Company Strategy and Product Development - The company is committed to achieving domestic innovation in the national data infrastructure sector, aiming to fill the long-term industrial gap in the high-end analog chip field in China [1] - Taorun Semiconductor has systematically constructed a product matrix that covers core points in the high-speed interconnection field, including the mass production of high-end chips such as 400G & 800G incoherent DSP chips and base station RF transceiver chips [1] Group 3: Ownership and Management - The actual controller of Taorun Semiconductor is Guan Yi, who holds a total shareholding ratio of 20.21% and a voting power of 40.34%, currently serving as the chairman and general manager of the company [1]